Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutr Cancer ; 65 Suppl 1: 78-87, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23682786

RESUMEN

Since bioantioxidants in plasma of Epidemic Dropsy patients [a condition caused by consumption of adulterated mustard oil with argemone oil (AO)] were found to be significantly decreased, the beneficial effect of N-acetyl cysteine (NAC) and α-tocopherol (TOCO) against AO- or sanguinarine (SANG)-induced tumorigenicity was undertaken in mice. Topical application of TOCO and NAC either alone or in combination showed significant protection against AO/TPA- and SANG/TPA-induced skin tumorigenicity. Histopathological findings suggest that papillomatous growth in AO/TPA- and SANG/TPA-treated animals were substantially protected following topical application of TOCO or NAC. Further, treatment of TOCO and NAC either alone or in combination to AO/TPA- or SANG/TPA-induced mice significantly decreased lipid peroxidation, along with significant revival in glutathione (GSH) content and activities of tyrosinase, histidase, catalase, SOD, GSH peroxidase, and GSH reductase in skin. In vitro studies showed that TOCO and/or NAC significantly decreased the AO and SANG induced cell proliferation and activation of ERK, p38, JNK MAPKs and NF-κB signaling in HaCaT cells. In summary, TOCO and NAC may be useful in preventing the tumorigenic response of AO and SANG probably by acting as scavenger of free radicals and inhibiting MAPKs and NF-κB signaling.


Asunto(s)
Acetilcisteína/farmacología , Carcinogénesis/efectos de los fármacos , Planta de la Mostaza/efectos adversos , Aceites de Plantas/efectos adversos , alfa-Tocoferol/farmacología , Animales , Antioxidantes/farmacología , Benzofenantridinas/efectos adversos , Carcinogénesis/inducido químicamente , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Femenino , Glutatión/análisis , Glutatión/metabolismo , Humanos , Isoquinolinas/efectos adversos , Peroxidación de Lípido/efectos de los fármacos , Sistema de Señalización de MAP Quinasas , Ratones , FN-kappa B/genética , FN-kappa B/metabolismo , Piel/efectos de los fármacos , Piel/patología , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA